类有机物
基质凝胶
药品
协议(科学)
医学
药物反应
抗癌药
药物开发
精密医学
计算生物学
药物发现
抗癌药物
癌症研究
癌症
肿瘤细胞
生物信息学
高含量筛选
计算机科学
药物试验
作者
Jung Sook Choi,Min Sang Lee,Myung Jin Song,Kwiwan Jeong
出处
期刊:STAR protocols
[Elsevier BV]
日期:2025-12-01
卷期号:6 (4): 104250-104250
被引量:5
标识
DOI:10.1016/j.xpro.2025.104250
摘要
Tumor organoids provide physiologically relevant three-dimensional (3D) models that overcome the limitations of two-dimensional cultures in drug screening. Here, we present a protocol for generating compact and reproducible ovarian cancer organoids using SKOV-3 cells embedded in growth-factor-reduced Matrigel and dispensed onto a 384-pillar plate. We describe automated cell-matrix dispensing, calcein-AM viability staining, and high-content fluorescence imaging for IC 50 analysis. This protocol enables scalable, standardized, and high-throughput drug screening with tumor organoids for quantitative drug efficacy evaluation.
科研通智能强力驱动
Strongly Powered by AbleSci AI